Hypertriglyceridemia Is Linked to Reduced Nitric Oxide Synthesis in Women with Hypertensive Disorders of Pregnancy

REFERENCES

• Brown DW, Dueker N, Jamieson DJ, Cole JW, Wozniak MA, Stern BJ, Giles WH, Kittner SJ. Preeclampsia and the risk of ischemic stroke among young women: results from the Stroke Prevention in Young Women Study. Stroke 2006; 37: 1055–1059
   PubMed Web of Science ®Google Scholar
• Ferrer Arreola L, Basavilvazo Rodriguez MA, Lemus Rocha R, Toca Porraz L, Hernandez Valencia M. Analysis of trends in maternal mortality during a 10-year follow up in a urban region. Ginecol Obstet Mex 2005; 73: 477–483
   PubMedGoogle Scholar
• Romero-Gutierrez G, Malacara JM, Amador N, Fierro-Martinez C, Munoz-Guevara LM, Molina-Rodriguez R. Homeostatic model assessment and risk for hypertension during pregnancy: a longitudinal prospective study. Am J Perinatol 2004; 21: 455–462
   PubMedGoogle Scholar
• Dekker GA, Robillard PY. Preeclampsia: a couple's disease with maternal and fetal manifestations. Curr Pharm Des 2005; 11: 699–710
   PubMed Web of Science ®Google Scholar
• Saarelainen H, Laitinen T, Raitakari OT, Juonala M, Heiskanen N, Lyyra-Laitinen T, Viikari JS, Vanninen E, Heinonen S. Pregnancy-related hyperlipidemia and endothelial function in healthy women. Circ J 2006; 70: 768–772
   PubMedGoogle Scholar
• Bayhan G, Kocyigit Y, Atamer A, Atamer Y, Akkus Z. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia. Gynecol Endocrinol 2005; 21: 1–6
   PubMed Web of Science ®Google Scholar
• Vadachkoria S, Woelk GB, Mahomed K, Qiu C, Muy-Rivera M, Malinow MR, Williams MA. Elevated soluble vascular cell adhesion molecule-1, elevated Homocyst(e)inemia, and hypertriglyceridemia in relation to preeclampsia risk. Am J Hypertens 2006; 19: 235–242
   PubMed Web of Science ®Google Scholar
• Ray JG, Diamond P, Singh G, Bell CM. Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG 2006; 113: 379–386
   PubMed Web of Science ®Google Scholar
• Enquobahrie DA, Williams MA, Butler CL, Frederick IO, Miller RS, Luthy DA. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens 2004; 17: 574–581
   PubMed Web of Science ®Google Scholar
• Ranta V, Viinikka L, Halmesmaki E, Ylikorkala O. Nitric oxide production with preeclampsia. Obstet Gynecol 1999; 93: 442–445
   PubMed Web of Science ®Google Scholar
• Diejomaoh FM, Omu AE, Al-Busiri N, Taher S, Al-Othman S, Fatinikun T, Fernandes S. Nitric oxide production is not altered in preeclampsia. Arch Gynecol Obstet 2004; 269: 237–243
   PubMedGoogle Scholar
• Wang Y, Gu Y, Zhang Y, Lewis DF. Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia. Am J Obstet Gynecol 2004; 190: 817–824
   PubMed Web of Science ®Google Scholar
• Choi JW, Im MW, Pai SH. Nitric oxide production increases during normal pregnancy and decreases in preeclampsia. Ann Clin Lab Sci 2002; 32: 257–263
   PubMed Web of Science ®Google Scholar
• Qiu C, Williams MA, Leisenring WM, Sorensen TK, Frederick IO, Dempsey JC, Luthy DA. Family history of hypertension and type 2 diabetes in relation to preeclampsia risk. Hypertension Mar, 2003; 41: 408–413
   PubMed Web of Science ®Google Scholar
• Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA 2005; 294: 2751–2757
   PubMed Web of Science ®Google Scholar
• DeLong DM, DeLong ER, Wood PD, Lippel K, Rifkind BM. A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study. JAMA 1986; 256: 2372–2377
   PubMed Web of Science ®Google Scholar
• Nisell H. Is carbohydrate metabolism altered among women who have undergone a preeclamptic pregnancy?. Gynecol Obstet Invest 1999; 48: 44–48
   Google Scholar
• Innes KE. Altered metabolic profiles among older mothers with a history of preeclampsia. Gynecol Obstet Invest 2005; 59: 192–201
   PubMedGoogle Scholar
• Rowe J, Campbell S, Gallery ED. Nitric oxide production by decidual endothelial cells is not reduced in preeclampsia. Hypertens Pregnancy 2003; 22: 63–75
   PubMed Web of Science ®Google Scholar
• Mutlu-Turkoglu U, Aykac-Toker G, Ibrahimoglu L, Ademoglu E, Uysal M. Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery. Gynecol Obstet Invest 1999; 48: 247–250
   PubMed Web of Science ®Google Scholar
• Solomon CG, Seely EW. Brief review: hypertension in pregnancy: A manifestation of the insulin resistance syndrome?. Hypertension 2001; 37: 232–239
   PubMed Web of Science ®Google Scholar
• Ma RM, Lao TT. Maternal mean arterial pressure and oral glucose tolerance test results. Relationship in normotensive women. J Reprod Med 2001; 46: 747–751
   PubMedGoogle Scholar
• Barden A, Singh R, Walters BN, Ritchie J, Roberman B, Beilin LJ. Factors predisposing to pre-eclampsia in women with gestational diabetes. J Hypertens 2004; 22: 2371–2378
   PubMed Web of Science ®Google Scholar
• Villamor E, Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet 2006; 30: 1164–1170
   Google Scholar
• Martin A, AJ O'sullivan, Brown MA. Body composition and energy metabolism in normotensive and hypertensive pregnancy. BJOG 2001; 108: 1263–1271
   PubMedGoogle Scholar
• Catov JM, Ness RB, Kip KE, Olsen J. Risk of early or severe preeclampsia related to pre-existing conditions. Intl J Epidemiol 2007; 36: 412–419
   PubMed Web of Science ®Google Scholar
• Erez-Weiss I, Erez O, Shoham-Vardi I, Holcberg G, Mazor M. The association between maternal obesity, glucose intolerance and hypertensive disorders of pregnancy in nondiabetic pregnant women. Hypertens Pregnancy 2005; 24: 125–136
   PubMed Web of Science ®Google Scholar
• Kompoti M, Mariolis A, Alevizos A, Kyrazis I, Protopsaltis I, Dimou E, Lentzas I, Levisianou D, Gova A, Melidonis A. Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes. Cardiovasc Diabetol 2006; 4: 5–21
   Google Scholar
• Forest JC, Girouard J, Masse J, Moutquin JM, Kharfi A, Ness RB, Roberts JM, Giguere Y. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol 2005; 105: 1373–1380
   PubMed Web of Science ®Google Scholar
• Cohn GS, Kittleson MM, Blumenthal RS. Toward an improved diagnosis of the metabolic syndrome other clues to the presence of insulin resistance. Am J Hypertens 2005; 18: 1099–1103
   PubMedGoogle Scholar
• Marchesi S, Lupattelli G, Siepi D, Roscini AR, Vaudo G, Sinzinger H, Mannarino E. Oral L-arginine administration attenuates postprandial endothelial dysfunction in young healthy males. J Clin Pharm Ther 2001; 26: 343–349
   PubMedGoogle Scholar
• Reynolds SS, Yanek LR, Vaidya D, Mora S, Moy TF, Saudek CD, Becker LC, Becker DM. Glucose levels in the normal range predict incident diabetes in families with premature coronary heart disease. Diabetes Res Clin Pract 2006; 74: 267–273
   PubMedGoogle Scholar
• Roes EM, Sieben R, Raijmakers MT, Peters WH, Steegers EA. Severe preeclampsia is associated with a positive family history of hypertension and hypercholesterolemia. Hypertens Pregnancy 2005; 24: 259–271
   PubMed Web of Science ®Google Scholar
• Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005; 330: 565
   PubMed Web of Science ®Google Scholar